Browse
Submit Data
Databases
API
Help

Dataset Information

23 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

(Dimethyl-formamide-?O)(2-hy-droxy-benzoato-?O,O)[tris-(1-methyl-1H-benzimidazol-2-ylmethyl-?N)amine-?N]manganese(II) perchlorate dimethyl-formamide monosolvate.

ABSTRACT: In the title complex, [Mn(C(7)H(5)O(3))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand coordinates in a tetra-dentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethyl-formamide ligand. The hy-droxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites with occupancies of 0.581?(8) and 0.419?(8). Both disorder components of the hy-droxy group form intra-molecular O-H?O hydrogen bonds.

SUBMITTER: Wu H

PROVIDER: S-EPMC2983134 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

(Dimethyl-formamide-κO)(2-hy-droxy-benzoato-κO,O)[tris-(1-methyl-1H-benzimidazol-2-ylmethyl-κN)amine-κN]manganese(II) perchlorate dimethyl-formamide monosolvate.

Wu Huilu H Bai Ying Y Huang Xingcai X Meng Xuan X Qi Baoliang B

Acta crystallographica. Section E, Structure reports online 20100911 Pt 10

In the title complex, [Mn(C(7)H(5)O(3))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is coordinated in a slightly distorted monocapped trigonal-prismatic geometry. The tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand coordinates in a tetra-dentate mode and the coordination is completed by a bis-chelating salicylate ligand and a dimethyl-formamide ligand. The hy-droxy group and the ortho H atoms of the salicylate ligand were refined as disordered over two sites wit ...[more]

PMID: 21587401

Similar Datasets

(2-Hydroxy-benzoato-?O)[tris-(1-methyl-benzimidazol-2-ylmethyl-?N)amine-?N]cobalt(II) perchlorate dimethyl-formamide sesquisolvate.

Project description:In the title complex, [Co(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Co(II) ion is five-coordinated by four N atoms from a tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The perchlorate ion is disordered over two sites with equal occupancy. One dimethyl-formamide solvent mol-ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl-formamide mol-ecule is disordered about a twofold rotation axis. There is an intra-molecular O-H?O hydrogen bond in the cation.

| S-EPMC2959500 | biostudies-literature

Salicylato[tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate dimethyl-formamide sesquisolvate.

Project description:In the title complex, [Zn(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·1.5C(3)H(7)NO, the Zn(II) atom is five-coordinated by four N atoms from a tris-(N-methyl-benzimidazol-2-ylmeth-yl)amine ligand and one O atom from a salicylate ligand in a distorted trigonal-bipyramidal geometry (? parameter = 0.84), with approximate mol-ecular C(3) symmetry. One dimethyl-formamide mol-ecule lies on a general position and is disordered over two coplanar orientations with equal occupancy. A second dimethyl-formamide mol-ecule is disordered about a twofold rotation axis.

| S-EPMC2915077 | biostudies-literature

Acrylato[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]cobalt(II) perchlorate-dimethyl-formamide-methanol (2/2/3).

Project description:In the title complex, [Co(C(3)H(3)O(2))(C(27)H(27)N(7))]ClO(4)·C(3)H(7)NO·1.5CH(4)O, the Co(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine (mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.90 and 0.10. In addition, the solvent hemimethanol mol-ecule is disordered over two positions with equal occupancies. The crystal structure is stabilized by weak intermolecular O-H?O hydrogen bonds.

| S-EPMC2959638 | biostudies-literature

(Dimethyl-formamide)(2-methyl-propen-oato)[tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine]-manganese(II) perchlorate dimethyl-formamide solvate.

Project description:In the title complex, [Mn(C(4)H(5)O(2))(C(27)H(27)N(7))(C(3)H(7)NO)]ClO(4)·C(3)H(7)NO, the Mn(II) ion is seven-coordinated in a distorted monocapped trigonal-prismatic geometry formed by a tetra-dentate tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine mol-ecule, a bidentate 2-methacrylate anion and a dimethyl-formamide mol-ecule. The methyl groups of the coordinated dimethyl-formamide mol-ecule and the perchlorate anions are disordered over two positions with occupancy factors of 0.640?(8) and 0.360?(8).

| S-EPMC2983334 | biostudies-other

Acrylato[tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine]zinc(II) perchlorate-dimethyl-formamide-methanol (1/1/1.5)?at 153?(2) K.

Project description:In the title complex, [Zn(C(3)H(3)O(2))(C(27)H(27)N(7))](ClO(4))·C(3)H(7)NO·1.5CH(4)O, the Zn(II) ion is five-coordinated by four N atoms from a tris-(1-methyl-benzimidazol-2-ylmeth-yl)amine (Mentb) ligand and one O atom from an acrylate ligand in a distorted trigonal-bipyramidal geometry with approximate mol-ecular C(3) symmetry. The atoms of the acrylate ligand are disordered over two sites, with approximate occupancies of 0.84 and 0.16. In addition, a methanol solvent mol-ecule is disordered over two sites with equal occupancies. In the crystal structure, the full-occupancy methanol is linked to a dimethyl-formamide mol-ecule by an inter-molecular O-H?O hydrogen bond.

| S-EPMC2960207 | biostudies-literature

(Salicylato)[tris-(1-methyl-1H-benz-imidazol-2-ylmeth-yl)amine]copper(II) perchlorate dimethyl-formamide disolvate.

Project description:In the title complex, [Cu(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·2C(3)H(7)NO, the Cu(II) ion is five-coordinated by four N atoms from the tris-(1-methyl-1H-benzimidazol-2-ylmeth-yl)amine ligand and an O atom of the monodentate salicylate ligand. The N(4)O donor set defines a coordination geometry inter-mediate between square-pyramidal and trigonal-bipyramidal. The crystal structure is stabilized by O-H⋯O inter-actions. The atoms of the aromatic ring of the salicylate ligand are disordered over two sites of equal occupancy. In addition, one of the dimethyl-formamide solvent mol-ecules is partially disordered over two positions, of approximately equal occupancy.

| S-EPMC2914911 | biostudies-literature

Aqua-{tris-[(1H-benzimidazol-2-yl-?N)meth-yl]amine}-zinc 5-(dimethyl-amino)-naphthalene-1-sulfonate perchlorate 2.5-hydrate.

Project description:In the title compound, [Zn(C(24)H(21)N(7))(H(2)O)](C(12)H(12)NO(3)S)(ClO(4))·2.5H(2)O, the Zn(II) ion is in a distorted trigonal-bipyramidal coordination geometry. In the crystal, N-H?O and O-H?O hydrogen bonds connect the components into a two-dimensional network parallel to (001). In addition, there are weak C-H?O hydrogen bonds.

| S-EPMC3238661 | biostudies-literature

Tris(2,2'-bi-1H-imidazole-?N,N)-nickel(II) dinitrate N,N-dimethyl-formamide monosolvate.

Project description:The reaction of nickel salts and 4,4'-bipyridine with 2,2'-bi-imidazole (H(2)biim) yielded the title complex, [Ni(C(6)H(6)N(4))(3)](NO(3))(2)·C(3)H(7)NO. The Ni(II) atom is chelated by three H(2)biim ligands in a distorted octa-hedral coordination geometry. The two nitrate anions and one dimethyl-formamide (DMF) mol-ecule are not coordinated. The compound has a three-dimensional structure, formed by extensive hydrogen bonding between [Ni(H(2)biim)(3)](2+) cations and nitrate anions, each nitrate anion forming hydrogen bonds with an R(1) (2)(4) motif. The DMF molecule is disordered over three sets of sites, with occupancy ratios of 0.341?(16):0.350?(17):0.309?(19).

| S-EPMC3247001 | biostudies-literature

Bis[1,3-bis(1-propyl-1H-benzimidazol-2-yl)-2-oxapropane]-cadmium(II) dipicrate dimethyl-formamide monosolvate.

Project description:In the title compound, [Cd(C(22)H(26)N(4)O)(2)](C(6)H(2)N(3)O(7))(2)·C(3)H(7)NO, the Cd(II) ion is coordinated by four N atoms and two O atoms from two tridentate 1,3-bis-(1-propyl-1H-benzimidazol-2-yl)-2-oxopropane ligands in a distorted octa-hedral coordination environment. There are significant differences in the chemically equivalent Cd-O bond lengths [2.618?(2)?Å and 2.561?(2)?Å].

| S-EPMC3201538 | biostudies-literature

Poly[bis-(dimethyl-ammonium) [bis-(dimethyl-amine-?N)tris-(?(2)-terephthalato-?O:O)dizinc(II)] N,N-dimethyl-formamide disolvate hexa-hydrate].

Project description:The title compound, {(C(2)H(8)N)(2)[Zn(2)(C(8)H(4)O(4))(3)(C(2)H(7)N)(2)]·2C(3)H(7)NO·6H(2)O}(n), consists of two-dimensional non-inter-penetrated sheets with 6(3) topology, which are stacked together in an …ABAB… packing mode along the c axis. The distance between adjacent A and B sheets is ca 7.3?Å. In the structure, the Zn(II) center is coordinated by three O atoms from three terephthalate groups and one N atom from one dimethyl-amine ligand, adopting a distorted tetra-hedral geometry. All solvent water mol-ecules are disordered. In the structure, N-H?O and O-H?O hydrogen bonds are observed.

| S-EPMC2970138 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data